Structure-function relationship of 3-phosphoglycerate analogues with platelet aggregation and thromboxane A2 formation.
We have studied the effects of 2,3-diphosphoglycerate (2,3-DPG), 3-phosphoglycerate (3-PG), 3-phosphoglyceraldehyde (3-PGA), 2-phosphoglycerate (2-PG) and beta-glycerol phosphate (beta-GP) on platelet aggregation and on thromboxane B2 (TXB2) formation. The results show that 2,3-DPG, 3-PG, and 3-PGA inhibited platelet aggregation and TXB2 formation induced by norepinephrine, ADP, epinephrine, and collagen; but they also induced platelet aggregation and TXB2 formation in the presence of subthreshold concentrations of Na arachidonate. 2-PG and beta-GP were inactive. The results also show that there is a structure-function relationship between 2,3-DPG, 3-PG, and 3-PGA with platelet aggregation phenomena and prostaglandin synthesis.
D019794:2,3-Diphosphoglycerate; D004163:Diphosphoglyceric Acids / Q000494:pharmacology; D005260:Female; D005988:Glyceric Acids; D006801:Humans; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D013329:Structure-Activity Relationship; D013928:Thromboxane A2 / Q000096:biosynthesis*; D013929:Thromboxane B2 / Q000096:biosynthesis*
D004163:Diphosphoglyceric Acids; D005988:Glyceric Acids; D019794:2,3-Diphosphoglycerate; D013929:Thromboxane B2; D013928:Thromboxane A2; C005156:3-phosphoglycerate